DM, F., T, P., AM, D., A, W., CM, P., E, C. D., & LA, C. (2022). Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer. Breast cancer research and treatment, 196(1), 153. https://doi.org/10.1007/s10549-022-06700-6
Chicago Style (17th ed.) CitationDM, File, Pascual T, Deal AM, Wheless A, Perou CM, Claire Dees E, and Carey LA. "Clinical Subtype, Treatment Response, and Survival in De Novo and Recurrent Metastatic Breast Cancer." Breast Cancer Research and Treatment 196, no. 1 (2022): 153. https://doi.org/10.1007/s10549-022-06700-6.
MLA (9th ed.) CitationDM, File, et al. "Clinical Subtype, Treatment Response, and Survival in De Novo and Recurrent Metastatic Breast Cancer." Breast Cancer Research and Treatment, vol. 196, no. 1, 2022, p. 153, https://doi.org/10.1007/s10549-022-06700-6.